Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARL4C - Recombinant Interferon α effect on natural killer cells in vitro
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARL4C - Type 2 diabetes: pancreatic beta-cells
ARL4C - Natural killer cell response to interleukin-2 treatment: time course
ARL4C - HIV-1 Vpr effect on monocyte-derived macrophage
ARL4C - Peripheral blood mononuclear cells and the effect of exercise
ARL4C - Systemic lupus erythematosus CD3+ T cells
ARL4C - Colon cancer cell lines with acquired resistance to BRAF inhibitor
ARL4C - Rheumatoid arthritic synovium response to methotrexate
ARL4C - T-cell acute lymphoblastic leukemia with CALM-AF10 fusion
ARL4C - Core binding factor-acute myeloid leukemia patients: mononuclear cells
ARL4C - Inhibition of Notch signaling in T cell acute lymphoblastic leukemia cell lines
ARL4C - HIV infection effect on CD4+ and CD8+ T cells
ARL4C - Early T-cell precursor acute lymphoblastic leukemia
ARL4C - Celiac disease: intraepithelial cytotoxic T lymphocytes
ARL4C - Identical twins discordant for Multiple sclerosis: CD4+ and CD8+ T cells
ARL4C - CD3+ T cell response to stimulation with CD3/CD28 or nitric oxide
ARL4C - Leukemic white blood cells and various RNA preparation protocols
ARL4C - IGHV mutated/unmutated Mantle Cell Lymphoma patients: B cell lymphocytes
ARL4C - Programmed Death-1-expressing CD8 T cells in healthy adult peripheral blood
ARL4C - Periodontal therapy effect on peripheral blood monocytes: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on